Harvey Investment Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-511
Closed -$251K 101
2026
Q1
$251K Hold
511
0.03% 94
2025
Q4
$296K Hold
511
0.03% 89
2025
Q3
$248K Hold
511
0.03% 99
2025
Q2
$207K Hold
511
0.02% 101
2025
Q1
$254K Hold
511
0.03% 96
2024
Q4
$266K Hold
511
0.03% 93
2024
Q3
$316K Hold
511
0.04% 87
2024
Q2
$283K Hold
511
0.03% 88
2024
Q1
$297K Hold
511
0.03% 85
2023
Q4
$271K Hold
511
0.03% 83
2023
Q3
$259K Hold
511
0.03% 83
2023
Q2
$267K Hold
511
0.03% 83
2023
Q1
$295K Hold
511
0.04% 82
2022
Q4
$281K Hold
511
0.04% 84
2022
Q3
$259K Hold
511
0.04% 84
2022
Q2
$278K Hold
511
0.04% 82
2022
Q1
$302K Hold
511
0.04% 83
2021
Q4
$341K Hold
511
0.04% 83
2021
Q3
$292K Hold
511
0.04% 83
2021
Q2
$258K Hold
511
0.03% 88
2021
Q1
$233K Hold
511
0.03% 90
2020
Q4
$238K Hold
511
0.03% 88
2020
Q3
$226K Buy
+511
New +$211K 0.04% 86

Other funds holding TMO

Harvey Investment Company's TMO Position: Q2 2026 in Review

Harvey Investment Company sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 511 shares — an estimated $251K sold.

Harvey Investment Company first reported a position in TMO in Q3 2020 and held it in 23 quarters. The position peaked at $341K in Q4 2021. 976 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Harvey Investment Company reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Harvey Investment Company sold 511 Thermo Fisher Scientific shares in Q2 2026, an estimated $251K.
  • Harvey Investment Company first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 23 quarters.
  • Harvey Investment Company's Thermo Fisher Scientific position peaked at $341K in Q4 2021.
  • 976 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Harvey Investment Company's 13F filing for Q2 2026, filed 22 Jul 2026.